In an unprecedented event, the gene regulatory program of healthy individuals has been extensively manipulated on a massive scale for the first time in human history.
Contrary to previous information, it has now come to light that RNA-based COVID-19 injections were not formulated using traditional messenger RNA (mRNA) but rather incorporated modified RNA (modRNA).
The presence of modRNA in these vaccines raises significant health concerns.
These risks extend beyond the current COVID-19 injections and boosters. If action is not taken promptly, they may also apply to all future RNA-based vaccines.
It is crucial to voice these concerns now to address the potential risks associated with modified RNA technology.
Distinguishing Between mRNA and modRNA in COVID-19 Vaccines
mRNA and modRNA are fundamentally distinct entities.
mRNA occurs naturally in our cells and has a brief lifespan, being relatively delicate. It serves as a specific type of RNA that carries essential instructions or “messages” from our genes, aiding in the production of proteins, which are the fundamental building blocks of our cells. As part of regular cellular processes, mRNA is continuously produced. Once its mission of delivering the messages is fulfilled, it undergoes degradation in the body.
When foreign RNA, such as viral RNA, enters our cells, these cells can generate proteins related to the invading virus.
We have been informed that COVID-19 injections utilize mRNA. However, a vaccine using “natural” mRNA would not persist long enough to initiate an immune response before being eliminated by our immune system.
To make mRNA viable for routine medical applications, scientists needed to artificially modify it to enhance both its efficiency and lifespan. The outcome of this enhancement is referred to as modRNA.
modRNA is designed for prolonged stability and maximal translation. Unlike mRNA, which displays a cell-specific expression pattern, modRNA can penetrate almost any cell type. This adaptability allows modRNA to be more effective in its intended medical applications.
The Journey of mRNA and the Advent of modRNA
In 1961, the discovery of mRNA was a moment of great scientific excitement, building upon earlier observations of this essential but short-lived RNA intermediary. Scientists unraveled its role in carrying genetic instructions from the cell’s DNA to ribosomes, where specific proteins are synthesized.
Researchers soon began exploring the potential of using mRNA to aid the body in healing itself. In 1990, they injected natural, unmodified mRNA into a mouse’s skeletal muscle, prompting the production of a protein that the mouse would not naturally generate.
However, they found that transferring natural mRNA was inefficient and short-lived, hindering its therapeutic application. This led to the development of synthetic modRNA, with the primary focus initially aimed at reprogramming and eliminating cancer cells.
modRNA 101: The Process of Modification
Modifying RNA involves altering one of the four compounds in RNA, such as transforming natural nucleoside uridine into synthetic methyl-pseudouridine. The resulting modRNA offers several advantages:
- Increased Stability: modRNA lasts longer in the body.
- Reduced Immunogenicity: It triggers less stimulation of the innate immune system.
- Enhanced Efficiency: modRNA produces more protein compared to the same amount of mRNA.
modRNA is synthesized in a laboratory.
Challenges and Risks of Using modRNA Therapeutically
Alarming as it may be, modRNA contains a viral gene sequence that can take control of a cell’s machinery and force it to produce viral proteins, like the spike protein in the case of COVID-19 vaccines.
Significantly, scientists were aware that targeted delivery of modRNA to specific cells was not feasible when creating COVID-19 vaccines and boosters. As a result, modRNA attacks healthy cells, even bypassing natural barriers like the blood-brain barrier.
The constant production of artificial viral proteins drains the cell of energy, disrupts its metabolism, and hinders its essential functions for the overall organism. Subsequently, the immune system destroys these infected cells.
Despite these concerns, Pfizer-BioNTech and Moderna proceeded with large-scale production of COVID-19 vaccines using modRNA.
Differences Between Natural Infection and modRNA Injection Responses
The spike protein, a component of the virus, is considered harmful to the body.
In a natural infection, our immune system neutralizes the virus through specific antibodies, offering potential cross-immunity against virus variants.
However, with modRNA injection, the immune system cannot prevent the lipid nanoparticles from delivering modRNA to all cells, regardless of whether they possess the appropriate receptor for virus binding. This differs from natural infection, where only specific cells are affected.